Xylem Inc. (NYSE:XYL) has been assigned a consensus rating of “Buy” from the fifteen research firms that are currently covering the firm, Marketbeat reports. Five research analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $60.30.
A number of brokerages have commented on XYL. Cowen and Company restated a “buy” rating and issued a $70.00 target price on shares of Xylem in a research note on Thursday. Stifel Nicolaus restated a “hold” rating and issued a $63.00 target price on shares of Xylem in a research note on Tuesday, September 5th. Boenning Scattergood reiterated an “outperform” rating on shares of Xylem in a research report on Tuesday, September 5th. Royal Bank Of Canada boosted their price objective on Xylem from $58.00 to $64.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 2nd. Finally, Oppenheimer Holdings, Inc. boosted their price objective on Xylem from $60.00 to $66.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 2nd.
ILLEGAL ACTIVITY NOTICE: This story was published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright law. The legal version of this story can be read at https://sportsperspectives.com/2017/09/22/analysts-set-xylem-inc-xyl-target-price-at-60-30.html.
Xylem (NYSE:XYL) traded up 1.28% during mid-day trading on Friday, reaching $64.75. The company’s stock had a trading volume of 771,073 shares. The stock has a market capitalization of $11.63 billion, a price-to-earnings ratio of 41.80 and a beta of 1.17. The firm has a 50-day moving average of $60.96 and a 200-day moving average of $54.45. Xylem has a 52 week low of $45.60 and a 52 week high of $64.80.
Xylem (NYSE:XYL) last issued its earnings results on Tuesday, August 1st. The industrial products company reported $0.59 EPS for the quarter, beating the Zacks’ consensus estimate of $0.57 by $0.02. Xylem had a return on equity of 17.26% and a net margin of 6.58%. The company had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same period in the previous year, the firm posted $0.48 earnings per share. Xylem’s quarterly revenue was up 24.9% compared to the same quarter last year. On average, equities research analysts expect that Xylem will post $2.37 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Wednesday, September 20th. Shareholders of record on Thursday, August 31st were given a $0.18 dividend. The ex-dividend date of this dividend was Tuesday, August 29th. This represents a $0.72 dividend on an annualized basis and a yield of 1.11%. Xylem’s dividend payout ratio (DPR) is 46.45%.
In other Xylem news, Director Steven R. Loranger sold 66,132 shares of the company’s stock in a transaction that occurred on Thursday, June 29th. The stock was sold at an average price of $55.01, for a total value of $3,637,921.32. Following the completion of the sale, the director now directly owns 65,030 shares in the company, valued at $3,577,300.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Kenneth Napolitano sold 9,052 shares of the company’s stock in a transaction that occurred on Wednesday, August 9th. The stock was sold at an average price of $60.16, for a total value of $544,568.32. Following the completion of the sale, the insider now owns 35,303 shares of the company’s stock, valued at $2,123,828.48. The disclosure for this sale can be found here. Corporate insiders own 0.75% of the company’s stock.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in XYL. Vanguard Group Inc. increased its holdings in shares of Xylem by 2.4% in the second quarter. Vanguard Group Inc. now owns 17,697,791 shares of the industrial products company’s stock valued at $980,989,000 after buying an additional 409,920 shares in the last quarter. BlackRock Inc. increased its holdings in shares of Xylem by 2,452.8% in the first quarter. BlackRock Inc. now owns 12,042,342 shares of the industrial products company’s stock valued at $604,765,000 after buying an additional 11,570,613 shares in the last quarter. State Street Corp increased its holdings in shares of Xylem by 11.5% in the second quarter. State Street Corp now owns 8,360,506 shares of the industrial products company’s stock valued at $460,211,000 after buying an additional 861,484 shares in the last quarter. Pictet Asset Management Ltd. increased its holdings in shares of Xylem by 7.9% in the second quarter. Pictet Asset Management Ltd. now owns 4,342,944 shares of the industrial products company’s stock valued at $226,441,000 after buying an additional 318,756 shares in the last quarter. Finally, FMR LLC increased its holdings in shares of Xylem by 7.7% in the second quarter. FMR LLC now owns 3,239,067 shares of the industrial products company’s stock valued at $179,541,000 after buying an additional 232,139 shares in the last quarter. Hedge funds and other institutional investors own 86.43% of the company’s stock.
Xylem Company Profile
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.